|
CN112190344A
|
|
Prevent new coronavirus splash negative pressure device
|
|
CN112185546A
|
|
Model for prognosis prediction of breast cancer patient and establishing method
|
|
CN112011620A
|
|
Application of circ-SLC38A1 as target in medicine for inhibiting bladder cancer cells
|
|
CN112175949A
|
|
Application of lncRNA RP11-394O4.6 in inhibition of biological functions of bladder cancer cells
|
|
CN112159847A
|
|
Expression profile and diagnosis model for predicting esophageal squamous cell carcinoma lymph node metastasis serum exosomal miRNAs
|
|
CN112280845A
|
|
Application of miR-328-3p in preparation of cerebral infarction and cerebral ischemia-reperfusion prognosis prediction reagent
|
|
CN111968115A
|
|
Method and system for detecting orthopedic consumables based on rasterization image processing method
|
|
CN111968114A
|
|
Orthopedics consumable detection method and system based on cascade deep learning method
|
|
CN111728661A
|
|
Parotid gland postoperative area pressurizing device and working method
|
|
CN111808186A
|
|
Human-derived secretory FNDC5 protein and preparation method and application thereof
|
|
CN111926078A
|
|
Application of ART5 in improving sensitivity of colorectal cancer to oxaliplatin
|
|
CN111909943A
|
|
Application of PRDX6 as target to enhancing sensitivity of colorectal cancer to oxaliplatin
|
|
CN111893181A
|
|
Application of PRDM16 in enhancing sensitivity of colorectal cancer to oxaliplatin
|
|
CN111944897A
|
|
Application of S1PR4 as target for enhancing sensitivity of colorectal cancer to oxaliplatin
|
|
CN111893180A
|
|
Application of LEF1 in enhancing sensitivity of colorectal cancer to oxaliplatin
|
|
CN111568893A
|
|
Docetaxel-resveratrol-co-loaded nano long-circulating liposome as well as preparation method and application thereof
|
|
CN111690744A
|
|
Biomarker for evaluating breast tumor progression and application thereof
|
|
CN111778330A
|
|
Colorectal cancer diagnosis biomarker and application thereof
|
|
CN111529529A
|
|
Application of thiazole-pyrazoline derivatives in preparation of non-small cell lung cancer resistant drugs
|
|
CN111514139A
|
|
Application of polyheterocycle-pyrazoline derivatives in preparation of non-small cell lung cancer resistant drugs
|
